MedOffice Saglik Endustri Anonim Sirketi FDA Record
- Latest inspection OAI · May 10, 2024
- Last warning letter 2024
MedOffice Saglik Endustri Anonim Sirketi has 0 FDA recalls, 1 inspection, 0 510(k) clearances and 1 compliance action on record. FDA has issued 1 warning letter to MedOffice Saglik Endustri Anonim Sirketi, the most recent on Oct 23, 2024.
- Latest inspection
- May 10, 2024 · OAI
Summary
| Records | Count | Last refreshed | Source as of | Status |
|---|---|---|---|---|
| Recalls | 0 | Nov 11, 2026 (checked Nov 15, 2026, unchanged) | File dated Nov 10, 2026 | Current |
| 510(k) clearances | 0 | Nov 15, 2026 | File dated Nov 9, 2026 | Current |
| Inspections | 1 | Nov 15, 2026 | Newest record Nov 5, 2026 | Current |
| Compliance actions | 1 | Nov 2, 2026 | Newest record Oct 29, 2026 | Current |
Reviewing MedOffice Saglik Endustri Anonim Sirketi as a supplier? Request a free FDA snapshot: name up to five suppliers and get a PDF of their public FDA record, with sources and dates. You do not need an API connection. Each snapshot is prepared by hand.
Or check MedOffice Saglik Endustri Anonim Sirketi yourself in Claude, Cursor or ChatGPT: get the full FDA risk summary, with inspections, warning letters, Form 483s and import alerts by site.
MedOffice Saglik Endustri Anonim Sirketi FDA Warning Letters
| Issued | Subject | Issuing office | Close-out letter |
|---|---|---|---|
| Oct 23, 2024 · Letter on fda.gov | CGMP/Finished Pharmaceuticals/Adulterated | Center for Drug Evaluation and Research (CDER) |
Recent FDA inspections
| Date | Site | Product | Classification | FEI |
|---|---|---|---|---|
| May 10, 2024 | Torbali, Turkey | Drugs | Official Action Indicated (OAI) | 3019167311 |
- NAI
- No objectionable conditions or practices were found during the inspection.
- VAI
- Objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action.
- OAI
- Regulatory and/or administrative actions are recommended.
Compliance Actions
FDA's compliance actions data lists 1 compliance action under MedOffice Saglik Endustri Anonim Sirketi: warning letters, injunctions and seizures. None came from FDA's Center for Tobacco Products.
FDA-inspected facilities
| Facility | Location | Inspections | Latest |
|---|---|---|---|
| FEI 3019167311 | Torbali, Turkey | 1 | May 10, 2024 |
MedOffice Saglik Endustri Anonim Sirketi and the FDA: common questions
Has MedOffice Saglik Endustri Anonim Sirketi received an FDA warning letter?
Yes. FDA has issued 1 warning letter to MedOffice Saglik Endustri Anonim Sirketi. The most recent is dated Oct 23, 2024, with the subject "CGMP/Finished Pharmaceuticals/Adulterated".
Has MedOffice Saglik Endustri Anonim Sirketi received an FDA Form 483?
FDA has not published a Form 483 for "MedOffice Saglik Endustri Anonim Sirketi" in its reading room. FDA publishes some Form 483s, not all of them.
When did the FDA last inspect MedOffice Saglik Endustri Anonim Sirketi?
The most recent FDA inspection on file ended May 10, 2024 at Torbali, Turkey and was classified OAI. FDA has 1 inspection of MedOffice Saglik Endustri Anonim Sirketi on file, 1 of them classified OAI (official action indicated).
Need more than this page shows? Ask about MedOffice Saglik Endustri Anonim Sirketi in Claude or ChatGPT and get every site's inspections, Form 483s, warning letters and import alerts, with a link to the FDA source for each record. The API key is free: no card.